Freedom Investment Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-104,063
Closed -$845K 811
2021
Q4
$845K Buy
104,063
+17,619
+20% +$173K 0.06% 399
2021
Q3
$1.09M Buy
86,444
+22,739
+36% +$315K 0.08% 303
2021
Q2
$986K Sell
63,705
-39,632
-38% -$666K 0.07% 333
2021
Q1
$2.09M Buy
103,337
+8,600
+9% +$213K 0.16% 147
2020
Q4
$2.56M Sell
94,737
-6,515
-6% -$146K 0.28% 78
2020
Q3
$1.87M Buy
101,252
+58,047
+134% +$1.03M 0.2% 101
2020
Q2
$769K Sell
43,205
-5,219
-11% -$79.4K 0.08% 194
2020
Q1
$829K Buy
48,424
+7,290
+18% +$109K 0.07% 223
2019
Q4
$704K Sell
41,134
-614
-1% -$8.2K 0.06% 265
2019
Q3
$434K Sell
41,748
-518
-1% -$6.96K 0.04% 390
2019
Q2
$659K Sell
42,266
-1,675
-4% -$29.9K 0.06% 293
2019
Q1
$806K Buy
43,941
+8,545
+24% +$151K 0.06% 283
2018
Q4
$589K Sell
35,396
-343
-1% -$7.95K 0.05% 385
2018
Q3
$1.03M Buy
35,739
+192
+0.5% +$5.52K 0.06% 315
2018
Q2
$1.01M Buy
35,547
+6,213
+21% +$185K 0.06% 341
2018
Q1
$924K Buy
29,334
+3,675
+14% +$116K 0.05% 395
2017
Q4
$748K Buy
+25,659
New +$699K 0.04% 481
2017
Q3
Sell
-10,687
Closed -$276K 1107
2017
Q2
$276K Buy
10,687
+2,287
+27% +$54.6K 0.02% 824
2017
Q1
$202K Buy
+8,400
New +$176K 0.01% 961

Other funds holding CLLS

Freedom Investment Management's CLLS Position: Q1 2022 in Review

Freedom Investment Management sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 104,063 shares — an estimated $845K sold.

Freedom Investment Management first reported a position in CLLS in Q1 2017 and held it in 19 quarters. The position peaked at $2.56M in Q4 2020. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • Freedom Investment Management reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • Freedom Investment Management sold 104,063 Cellectis shares in Q1 2022, an estimated $845K.
  • Freedom Investment Management first reported a position in Cellectis in Q1 2017 and held it in 19 quarters.
  • Freedom Investment Management's Cellectis position peaked at $2.56M in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.